From The Cancer Genome Atlas (TCGA) database, we found that FOXD2-AS1 was significantly increased in bladder cancer according to analysis of 19 pairs of cancer and adjacent noncancerous samples (Fig. 1a). The gene discussed is FOXD2; the disease is urinary bladder carcinoma.